Research ArticlePsoriatic Arthritis
Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice
Eva Galíndez-Agirregoikoa, Diana Prieto-Peña, José Luis Martín-Varillas, Beatriz Joven, Olga Rusinovich, Rafael B. Melero-González, Francisco Ortiz-Sanjuan, Raquel Almodóvar, Juan José Alegre-Sancho, Ángels Martínez, Agustí Sellas-Fernández, Lara Méndez, Rosario García-Vicuña, Belén Atienza-Mateo, Iñigo Gorostiza, Miguel Ángel González-Gay and Ricardo Blanco on behalf of the Tofacitinib PsA Clinical Practice Collaborative Group
The Journal of Rheumatology October 2021, 48 (10) 1552-1558; DOI: https://doi.org/10.3899/jrheum.201204
Eva Galíndez-Agirregoikoa
1E. Galíndez-Agirregoikoa, MD, Rheumatology Department, Hospital Universitario de Basurto, Bilbao;
Diana Prieto-Peña
2D. Prieto-Peña, MD, B. Atienza-Mateo, MD, R. Blanco, MD, PhD, Rheumatology Department, Hospital Universitario Marqués de Valdecilla, Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Santander;
José Luis Martín-Varillas
3J.L. Martín-Varillas, MD, Rheumatology Department, Hospital de Sierrallana, Torrelavega;
Beatriz Joven
4B. Joven, MD, Rheumatology Department, Hospital Universitario 12 de Octubre, Madrid;
Olga Rusinovich
5O. Rusinovich, MD, Rheumatology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid;
Rafael B. Melero-González
6R.B. Melero-González, MD, Rheumatology Department, Complexo Hospitalario Universitario de Vigo, Vigo;
Francisco Ortiz-Sanjuan
7F. Ortiz-Sanjuan, MD, PhD, Rheumatology Department, Hospital Universitario Politécnico La Fé, Valencia;
Raquel Almodóvar
8R. Almodóvar, MD, Rheumatology Department, Fundación Alcorcón, Madrid;
Juan José Alegre-Sancho
9J.J. Alegre-Sancho, MD, Á. Martínez, MD, Rheumatology Department, Hospital Universitario Doctor Peset, Valencia;
Ángels Martínez
9J.J. Alegre-Sancho, MD, Á. Martínez, MD, Rheumatology Department, Hospital Universitario Doctor Peset, Valencia;
Agustí Sellas-Fernández
10A. Sellas-Fernández, MD, Rheumatology Department, Hospital Universitari Arnau de Vilanova-Lleida, Lleida;
Lara Méndez
11L. Méndez, MD, Rheumatology Department, Hospital Virgen del Rocío, Sevilla;
Rosario García-Vicuña
12R. García-Vicuña, MD, PhD, Rheumatology Department, Hospital de la Princesa, IIS-Princesa, Cátedra UAM-Roche (EPID-Future), Universidad Autónoma de Madrid, Madrid;
Belén Atienza-Mateo
2D. Prieto-Peña, MD, B. Atienza-Mateo, MD, R. Blanco, MD, PhD, Rheumatology Department, Hospital Universitario Marqués de Valdecilla, Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Santander;
Iñigo Gorostiza
13I. Gorostiza, MD, Research Group, Hospital Universitario de Basurto, Bilbao;
Miguel Ángel González-Gay
14M.Á. González-Gay, MD, PhD, Rheumatology Department, Hospital Universitario Marqués de Valdecilla, Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, and University of Cantabria, School of Medicine, Santander, Spain, and Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Ricardo Blanco
2D. Prieto-Peña, MD, B. Atienza-Mateo, MD, R. Blanco, MD, PhD, Rheumatology Department, Hospital Universitario Marqués de Valdecilla, Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Santander;
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 48, Issue 10
1 Oct 2021
Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice
Eva Galíndez-Agirregoikoa, Diana Prieto-Peña, José Luis Martín-Varillas, Beatriz Joven, Olga Rusinovich, Rafael B. Melero-González, Francisco Ortiz-Sanjuan, Raquel Almodóvar, Juan José Alegre-Sancho, Ángels Martínez, Agustí Sellas-Fernández, Lara Méndez, Rosario García-Vicuña, Belén Atienza-Mateo, Iñigo Gorostiza, Miguel Ángel González-Gay, Ricardo Blanco
The Journal of Rheumatology Oct 2021, 48 (10) 1552-1558; DOI: 10.3899/jrheum.201204
Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice
Eva Galíndez-Agirregoikoa, Diana Prieto-Peña, José Luis Martín-Varillas, Beatriz Joven, Olga Rusinovich, Rafael B. Melero-González, Francisco Ortiz-Sanjuan, Raquel Almodóvar, Juan José Alegre-Sancho, Ángels Martínez, Agustí Sellas-Fernández, Lara Méndez, Rosario García-Vicuña, Belén Atienza-Mateo, Iñigo Gorostiza, Miguel Ángel González-Gay, Ricardo Blanco
The Journal of Rheumatology Oct 2021, 48 (10) 1552-1558; DOI: 10.3899/jrheum.201204